Spatial-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density

Nanoparticles hold great preclinical promise in cancer therapy but continue to suffer attrition through clinical trials. Advanced, three dimensional (3D) cellular models such as tumor spheroids can recapitulate elements of the tumor environment and are considered the superior model to evaluate nanoparticle designs. However, there is an important need to better understand nanoparticle penetration kinetics and determine how different cell characteristics may influence this nanoparticle uptake. A key challenge with current approaches for measuring nanoparticle accumulation in spheroids is that they are often static, losing spatial and temporal information which may be necessary for effective nanoparticle evaluation in 3D cell models. To overcome this challenge, we developed an analysis platform, termed the Determination of Nanoparticle Uptake in Tumor Spheroids (DONUTS), which retains spatial and temporal information during quantification, enabling evaluation of nanoparticle uptake in 3D tumor spheroids. Outperforming linear profiling methods, DONUTS was able to measure silica nanoparticle uptake to 10 µm accuracy in both isotropic and irregularly shaped cancer cell spheroids. This was then extended to determine penetration kinetics, first by a forward-in-time, center-in-space model, and then by mathematical modelling, which enabled the direct evaluation of nanoparticle penetration kinetics in different spheroid models. Nanoparticle uptake was shown to inversely relate to particle size and varied depending on the cell type, cell stiffness and density of the spheroid model. The automated analysis method we have developed can be applied to live spheroids in situ, for the advanced evaluation of nanoparticles as delivery agents in cancer therapy.

[1]  E. Crampin,et al.  Spatio-temporal analysis of nanoparticles in live tumor spheroids impacted by cell origin and density. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Yijia Wang,et al.  MS imaging of multicellular tumor spheroids and organoids as an emerging tool for personalized medicine and drug discovery , 2021, The Journal of biological chemistry.

[3]  O. Tillement,et al.  Quantifying nanotherapeutic penetration using a hydrogel-based microsystem as a new 3D in vitro platform. , 2021, Lab on a chip.

[4]  E. Crampin,et al.  Understanding nano-engineered particle–cell interactions: biological insights from mathematical models , 2021, Nanoscale advances.

[5]  O. Tillement,et al.  Quantifying nanotherapeutics penetration using hydrogel based microsystem as a new 3D in vitro platform , 2021, bioRxiv.

[6]  I. Manners,et al.  Investigating the influence of block copolymer micelle length on cellular uptake and penetration in a multicellular tumor spheroid model. , 2020, Nanoscale.

[7]  N. Voelcker,et al.  Patient‐Derived Prostate Cancer Explants: A Clinically Relevant Model to Assess siRNA‐Based Nanomedicines , 2020, Advanced healthcare materials.

[8]  N. Voelcker,et al.  Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin. , 2020, Biomaterials science.

[9]  N. Kulkarni,et al.  Development of pharmaceutically scalable inhaled anti-cancer nanotherapy - Repurposing amodiaquine for non-small cell lung cancer (NSCLC). , 2020, Materials science & engineering. C, Materials for biological applications.

[10]  J. Weis,et al.  Characterization of multicellular breast tumor spheroids using image data-driven biophysical mathematical modeling , 2020, Scientific Reports.

[11]  P. Kemmeren,et al.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity , 2020, Nature Communications.

[12]  S. Wilhelm,et al.  The entry of nanoparticles into solid tumours , 2020, Nature Materials.

[13]  G. Koellensperger,et al.  Quantitative imaging of silver nanoparticles and essential elements in thin sections of fibroblast multicellular spheroids by high resolution laser ablation inductively coupled plasma time-of-flight mass spectrometry (LA-ICP-TOF-MS). , 2019, Analytical chemistry.

[14]  P. Gellert,et al.  Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids. , 2019, Bioconjugate chemistry.

[15]  J. Quinn,et al.  Rapid Assessment of Nanoparticle Extravasation in a Microfluidic Tumor Model , 2019, ACS Applied Nano Materials.

[16]  E. Crampin,et al.  Quantifying the Influence of Nanoparticle Polydispersity on Cellular Delivered Dose , 2019, Biophysical Journal.

[17]  A. Seyfoori,et al.  Self-filling microwell arrays (SFMAs) for tumor spheroid formation. , 2018, Lab on a chip.

[18]  Chun-Xia Zhao,et al.  Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation. , 2018, ACS nano.

[19]  Edmund J. Crampin,et al.  Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.

[20]  P. Couvreur,et al.  Nanomedicines for Pediatric Cancers. , 2018, ACS nano.

[21]  Oliver Otto,et al.  Real-time fluorescence and deformability cytometry , 2018, Nature Methods.

[22]  Christopher M. Fife,et al.  Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma , 2018, Molecular Cancer Therapeutics.

[23]  Jong-Min Lim,et al.  Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.

[24]  K. Gaus,et al.  An intermolecular FRET sensor detects the dynamics of T cell receptor clustering , 2017, Nature Communications.

[25]  D. Winkler Computational Modelling of Magnetic Nanoparticle Properties and In Vivo Responses. , 2017, Current medicinal chemistry.

[26]  F. Danhier,et al.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[27]  W. Hennink,et al.  Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[28]  C. Fimognari,et al.  Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment , 2016, Oncotarget.

[29]  Vítor M Gaspar,et al.  3D tumor spheroids: an overview on the tools and techniques used for their analysis. , 2016, Biotechnology advances.

[30]  Dai Fukumura,et al.  Solid stress and elastic energy as measures of tumour mechanopathology , 2016, Nature Biomedical Engineering.

[31]  P. Kantoff,et al.  Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.

[32]  D. Edwards,et al.  Generation of an in vitro 3D PDAC stroma rich spheroid model. , 2016, Biomaterials.

[33]  Joseph W. Nichols,et al.  Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. , 2016, Nature nanotechnology.

[34]  Hanmei Bao,et al.  Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies , 2016, International journal of nanomedicine.

[35]  Chien-Chung Peng,et al.  Drug testing and flow cytometry analysis on a large number of uniform sized tumor spheroids using a microfluidic device , 2016, Scientific Reports.

[36]  E. Chang,et al.  Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine. , 2015, Biochemical and biophysical research communications.

[37]  X. Wan,et al.  Inverse relationship between elemental selenium nanoparticle size and inhibition of cancer cell growth in vitro and in vivo. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[38]  Shang‐Hsiu Hu,et al.  Targeted Mesoporous Iron Oxide Nanoparticles-Encapsulated Perfluorohexane and a Hydrophobic Drug for Deep Tumor Penetration and Therapy , 2015, Theranostics.

[39]  R. Minter,et al.  Identification of anti-tumour biologics using primary tumour models, 3-D phenotypic screening and image-based multi-parametric profiling , 2015, Molecular Cancer.

[40]  Yoo-Shin Kim,et al.  Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Hongxu Lu,et al.  Core-cross-linking Accelerates Antitumor Activities of Paclitaxel− Conjugate Micelles to Prostate Multicellular Tumor Spheroids: a Comparison of 2d and 3d Models , 2022 .

[42]  Victor G. Piazza,et al.  Quantitative imaging of cell dynamics in mouse embryos using light-sheet microscopy , 2014, Development.

[43]  S. Sagnella,et al.  Drug delivery: beyond active tumour targeting. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[44]  K. Ricketts,et al.  A 3D In Vitro Cancer Model as a Platform for Nanoparticle Uptake and Imaging Investigations , 2014, Small.

[45]  A. Tripathi,et al.  Multilayer Spheroids To Quantify Drug Uptake and Diffusion in 3D , 2014, Molecular pharmaceutics.

[46]  R. Whan,et al.  Dextran-based doxorubicin nanocarriers with improved tumor penetration. , 2014, Biomacromolecules.

[47]  Cyrille Boyer,et al.  Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin release. , 2013, ACS nano.

[48]  Philip S Low,et al.  Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. , 2013, ACS nano.

[49]  C. Allen,et al.  Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere® , 2013, PloS one.

[50]  Eric C. Carnes,et al.  Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility. , 2013, Accounts of chemical research.

[51]  S. Takayama,et al.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Qiao Jiang,et al.  Multicellular Tumor Spheroids as an in Vivo–Like Tumor Model for Three-Dimensional Imaging of Chemotherapeutic and Nano Material Cellular Penetration , 2012, Molecular imaging.

[53]  M. Dewhirst,et al.  Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors. , 2012, Cancer research.

[54]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[55]  M. Keating,et al.  Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells , 2011, The Journal of Biological Chemistry.

[56]  Yongxiang Gao,et al.  Accurate detection and complete tracking of large populations of features in three dimensions. , 2009, Optics express.

[57]  D. Khaitan,et al.  Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine , 2006, Expert opinion on drug discovery.

[58]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[59]  R. Pego,et al.  Analysis of binding reactions by fluorescence recovery after photobleaching. , 2004, Biophysical journal.

[60]  W. Webb,et al.  Focal volume optics and experimental artifacts in confocal fluorescence correlation spectroscopy. , 2002, Biophysical journal.

[61]  S. Torquato,et al.  Pattern of self‐organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model , 2001, Cell proliferation.

[62]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[63]  D Liberati,et al.  Forecasting the growth of multicell tumour spheroids: implications for the dynamic growth of solid tumours , 2000, Cell proliferation.

[64]  C. Fletcher Computational techniques for fluid dynamics , 1992 .

[65]  W. Webb,et al.  Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. , 1976, Biophysical journal.

[66]  Xunbin Wei,et al.  Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer. , 2017, Biomaterials.

[67]  Katharina Gaus,et al.  Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release. , 2017, Nature nanotechnology.

[68]  B. Stewart,et al.  World cancer report 2014. , 2014 .

[69]  Per-Olof Persson,et al.  A Simple Mesh Generator in MATLAB , 2004, SIAM Rev..

[70]  Clive A. J. Fletcher,et al.  Computational Fluid Dynamics: An Introduction , 1988 .